MSMercedes Sendín-Martín

Mercedes Sendín-Martín

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mercedes Sendín-Martín has a total of 45 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Risk of suicide in immune-mediated skin diseases: an overview of systematic reviews with meta-analysis

    by Juan-Carlos Hernández-Rodríguez, Rocío C. Bueno-Molina, Cristina García-Muñoz, Mercedes Sendín-Martín, Jose-Juan Pereyra-Rodriguez, Azahara Rodriguez-Luna, Javier Martinez-Calderon

  • Open Access

    Sociodemographic Disparities in Atopic Dermatitis Prevalence in Spain

    by Lucía Cayuela, Rocío C. Bueno-Molina, Juan-Carlos Hernández-Rodríguez, Mercedes Sendín-Martín, José-Juan Pereyra-Rodríguez, Aurelio Cayuela

    Background: Atopic dermatitis (AD) is a widespread, chronic inflammatory skin condition with substantial global impact. While regional studies have explored its prevalence in Spain, comprehensive national data detailing AD prevalence across various sociodemographic groups remain limited. Objective: This study aimed to estimate the 2023 prevalence of AD in Spain and explore disparities across key sociodemographic groups. Methods: We conducted a retrospective cross-sectional study using Spain’s National Health System Primary Care Clinical Database (BDCAP). We identified AD cases via ICPC code S87. We calculated crude and age-standardized prevalence rates (ASPRs) and rate ratios, stratified by sex, age, country of origin, municipality size, income, and employment status. The 2013 European Standard Population was used for age standardization. Results: In 2023, an estimated 2,706,675 individuals in Spain were living with AD, with women (1,451,216 cases) experiencing a higher burden than men (1,255,459 cases), and also presenting with a higher mean age (27.23 years vs. 22.96 years for men). Urban living showed a clear dose–response relationship with AD prevalence. In cities with over 500,000 inhabitants, ASPRs reached 7.74% in men and 8.52% in women; significantly higher than in rural areas, where rates were 5.66% and 6.57%, respectively. Individuals in the middle-income bracket (€18,000–€99,999) consistently exhibited the highest prevalence, and the non-active employment group also demonstrated an elevated risk (ASPRs: 6.51% for men, 7.28% for women). Finally, Spanish-born individuals generally had higher AD prevalence compared to most foreign-born populations. Conclusions: Atopic dermatitis in Spain displays significant sociodemographic disparities, with urban environments, female sex, and non-active employment status emerging as key risk factors. These findings underscore the importance of targeted public health interventions and equity-focused dermatological planning.

  • Open Access

    Incidence and mortality of nonmelanoma skin cancer in Europe: current trends and challenges

    by Mercedes Sendín-Martín, Rocío C. Bueno-Molina, Juan-Carlos Hernández-Rodríguez, Lucía Cayuela, Aurelio Cayuela, José-Juan Pereyra-Rodríguez

    Purpose: Nonmelanoma skin cancer (NMSC), predominantly basal cell carcinoma (BCC) and squamous cell carcinoma (SCC), represents the most common malignancy among fair-skinned populations. While BCC is rarely fatal, SCC contributes significantly to NMSC-related mortality. This study aimed to investigate long-term trends in NMSC incidence and SCC mortality across 28 European countries from 1992 to 2021, focusing on regional, sex-specific, and age-related variations. Methods/patients: A longitudinal ecological analysis was conducted using the Global Burden of Disease (GBD) database. Age-standardized incidence rates (ASIRs) for NMSC and age-standardized mortality rates (ASMRs) for SCC were calculated based on the 2013 European Standard Population. Temporal trends were evaluated using joinpoint regression, and age–period–cohort (APC) models were employed to disentangle independent effects on SCC mortality. Results: Europe registered over 27 million NMSC cases between 1992 and 2021. Overall ASIRs slightly declined, although increasing incidence was observed in individuals under 45 in Central and Northern Europe. SCC accounted for more than 570,000 deaths, with overall ASMRs decreasing—particularly among women and younger men. However, mortality rose in men aged over 75, notably in Northern and Western Europe. APC analysis indicated elevated SCC mortality in cohorts born before 1940, with a notable reversal in Northern European males born after 1960, who exhibited increasing mortality. Period effects further confirmed a recent rise in SCC mortality among these populations. Conclusions: Although NMSC incidence appears to be stabilizing or declining in much of Europe, increasing trends in younger individuals and rising SCC mortality in older men—especially in Northern Europe—highlight the need for age- and region-specific prevention and screening strategies. Improved cancer registry harmonization remains essential for guiding effective public health interventions. Graphical


  • Geospatial Analysis of Cutaneous Malignant Melanoma Epidemiology in Europe From 2017 to 2021

    by Rocío C. Bueno‐Molina, Mercedes Sendín‐Martín, Juan‐Carlos Hernández‐Rodríguez, Lucía Cayuela, Aurelio Cayuela, José‐Juan Pereyra‐Rodríguez

    Background: Cutaneous melanoma is the most aggressive form of skin cancer. Although some studies have explored the epidemiology of melanoma in Europe, there is limited data on its spatial distribution. Materials and Methods: A longitudinal ecological study was conducted to analyze melanoma incidence and mortality from 2017 to 2021 using data from the Global Burden of Disease database. Cases were identified using the International Classification of Diseases (ICD)‐9 and ICD‐10 codes for both sexes across four European geographical regions, excluding Russia. Age‐standardized incidence and mortality rates were calculated. A distance‐based spatial weights matrix was generated using GeoDa software to define neighborhood structure. Hotspot analysis of spatial clusters was conducted using the Getis‐Ord Gi* statistic. Additionally, the mortality‐to‐incidence ratio was calculated. Results: Between 2017 and 2021, a total of 606,448 new melanoma cases were diagnosed in Europe. Both sexes exhibited higher incidence and mortality rates in Northern Europe. All rates were consistently lower in women. For both sexes, incidence hotspots were identified in Sweden, Denmark, the Netherlands, and the United Kingdom. In contrast, mortality hotspots are primarily observed in the Nordic countries, as well as in Eastern Europe. Incidence coldspots are predominantly found in southeastern Europe, whereas mortality coldspots are primarily concentrated in Spain and Portugal. The overall mortality‐to‐incidence ratio in Europe remained stable during the period, with an evident east–west gradient and higher mortality relative to incidence observed in Eastern Europe. Conclusion: This analysis reveals distinct geographical patterns, characterized by a north–south gradient in incidence and mortality. In contrast, the mortality‐to‐incidence ratio follows an east–west gradient, highlighting significant disparities in healthcare access.


  • Trends in cutaneous malignant melanoma mortality in Europe from 1992 to 2021

    by Mercedes Sendín-Martín, Rocío C Bueno-Molina, Juan-Carlos Hernández-Rodríguez, Lucía Cayuela, Aurelio Cayuela, José-Juan Pereyra-Rodríguez

    Background: Cutaneous melanoma is the most aggressive skin cancer, causing 58 000 deaths globally in 2022. While incidence rates are rising, mortality trends vary globally, especially in Europe. Objectives: To analyse melanoma mortality trends across 28 European countries from 1992 to 2021, focusing on sex and specific age groups (< 45, 45–74 and ≥ 75 years). Methods: A longitudinal ecological study was conducted, using melanoma mortality data from the Global Burden of Disease database (1992–2021). Data from 28 European countries were categorized into four regions. We stratified mortality data by age and sex, calculating age-standardized mortality rates (ASMRs) using the 2013 European Standard Population. Joinpoint regression identified trend changes, analysing the independent effects of age, period and cohort factors. Results: Mortality rates varied significantly by country, sex and age. Patients aged > 75 years accounted for increased ASMRs until 2015, while younger patients’ mortality rates have declined since the 1990s. Notably, ASMRs for those aged > 75 years have stabilized or decreased in recent years. ASMRs rose for both male and female patients across all cohorts born up to the 1950s and 1960s, levelling off afterwards. However, recent cohorts in Central and Eastern Europe, along with men in Northern Europe, show an upward trend. Conclusions: This study highlights the complexity of melanoma mortality trends and the significant impacts of age and sex. The observed increases in Central and Eastern Europe and among male patients in Northern Europe necessitate continued monitoring and adaptive strategies to address potential mortality rate increases in these demographic groups.


  • Patterns and trends in melanoma mortality in Spain (1999–2022)

    by Lucía Cayuela, Juan-Carlos Hernández-Rodríguez, Jose-Juan Pereyra-Rodriguez, Mercedes Sendín-Martín, Aurelio Cayuela

    Aim To examine melanoma mortality trends in Spanish Autonomous Communities from 1999 to 2022, focusing on gender and age differences. Methods Data from the National Statistics Institute were used to calculate age-standardized mortality rates (ASMRs). Joinpoint regression identified trend changes. Results Melanoma mortality varied significantly by region, gender, and age. Eastern Spain had higher male mortality, while western regions had lower rates. Asturias had higher female mortality, with lower rates in Andalusia, Extremadura, and Castilla-La Mancha. Men generally exhibited higher ASMRs than women, with variations across regions. While ASMRs remained stable in most areas, Madrid experienced a notable decline (AAPC: − 1.3%). A national trend reversal occurred in 2014 (AAPC: − 1.3%). For individuals aged 45–74 years, Catalonia saw a significant decrease (AAPC: − 1.1%, p < 0.05), whereas Andalusia experienced an increase (APC: 2.1% since 2007). Nationally, ASMRs for this age group declined (AAPC: − 0.7%). Among those aged 75 years and over, ASMRs varied considerably, with increases observed in Andalusia and Aragon. Nationally, male ASMRs rose (AAPC: 1.6% per year), while female rates were stable. Regional disparities were evident, with higher female mortality in the Balearic Islands and fluctuating rates in the Community of Madrid (an increase followed by a decrease after 2015). The gender gap in mortality varied across regions, with some areas showing a narrowing gap and others widening disparities. Conclusion Continuous monitoring of melanoma mortality, especially among men and older adults, is crucial. Public health efforts should address regional disparities, improve early detection, and enhance treatment access to optimize outcomes nationwide.


  • Open Access

    Skin cancer mortality in Spain: adjusted mortality rates by province and related risk factors

    by Antonio Alcalá Ramírez del Puerto, Juan Carlos Hernández‐Rodriguez, Mercedes Sendín‐Martín, Juan Ortiz‐Alvarez, Julián Conejo‐Mir Sánchez, José Juan Pereyra‐Rodriguez

    Background: Ultraviolet radiation is the main environmental risk factor responsible for the development of skin cancer. Other occupational, socioeconomic, and environmental factors appear to be related to the risk of skin cancer. Furthermore, the factors appear to differ for melanoma and non‐melanoma skin cancer (NMSC). The purpose of this study is to analyze mortality rates of skin cancer in the different provinces of Spain and to determine the influence of socioeconomic conditions and other environmental and demographic factors in rates.Methods: Deaths from melanoma and NMSC in the period 2000–2019 were obtained as well as socioeconomic and environmental variables. Annual standardized mortality rates (SMR) were calculated for all Spanish provinces. The Pearson correlation coefficient was calculated.Results: The SMR of melanoma was 2.10/100,000 inhabitants, while that of NMSC was 1.28/100,000. At the provincial level, a great variability is confirmed. Gross domestic product showed a positive correlation with melanoma mortality but a negative correlation with NMSC. Other environmental and socioeconomic variables also showed correlation, as a positive correlation between tobacco sales and melanoma and between agricultural development and the NMSC.Conclusions: There are still important differences between each province that must be taken into account when planning health care and resource distribution. This ecological and province‐wise study helps to elucidate the relationship between social and ambient exposure determinants and skin cancer mortality in Spain.


  • Open Access

    Quantitative collagen analysis using second harmonic generation images for the detection of basal cell carcinoma with ex vivo multiphoton microscopy

    by Mercedes Sendín‐Martín, Jasmine Posner, Ucalene Harris, Matthew Moronta, Julián Conejo‐Mir Sánchez, Sushmita Mukherjee, Milind Rajadhyaksha, Kivanc Kose, Manu Jain

    Basal cell carcinoma (BCC) is the most common skin cancer, and its incidence is rising. Millions of benign biopsies are performed annually for BCC diagnosis, increasing morbidity, and healthcare costs. Non‐invasive in vivo technologies such as multiphoton microscopy (MPM) can aid in diagnosing BCC, reducing the need for biopsies. Furthermore, the second harmonic generation (SHG) signal generated from MPM can classify and prognosticate cancers based on extracellular matrix changes, especially collagen type I. We explored the potential of MPM to differentiate collagen changes associated with different BCC subtypes compared to normal skin structures and benign lesions. Quantitative analysis such as frequency band energy analysis in Fourier domain, CurveAlign and CT‐FIRE fibre analysis was performed on SHG images from 52 BCC and 12 benign lesions samples. Our results showed that collagen distribution is more aligned surrounding BCCs nests compared to the skin's normal structures (p < 0.001) and benign lesions (p < 0.001). Also, collagen was orientated more parallelly surrounding indolent BCC subtypes (superficial and nodular) versus those with more aggressive behaviour (infiltrative BCC) (p = 0.021). In conclusion, SHG signal from type I collagen can aid not only in the diagnosis of BCC but could be useful for prognosticating these tumors. Our initial results are limited to a small number of samples, requiring large‐scale studies to validate them. These findings represent the groundwork for future in vivo MPM for diagnosis and prognosis of BCC.


  • Systemic sclerosis mortality trends in Spain from 1980 to 2019: age–period–cohort and joinpoint analysis

    by Juan-Carlos Hernández-Rodríguez, Mercedes Sendín-Martín, Antonio-José Durán-Romero, Juan Ortiz Álvarez, Julián Conejo-Mir, José-Juan Pereyra-Rodríguez

    Background: Systemic sclerosis (SSc) is an autoimmune chronic rheumatic disease with a high mortality rate, which continues to be a challenge for clinicians today. Aim: To assess changes in mortality trends in the Spanish SSc population between 1980 and 2019, taking into account the independent effects of sex, age, time period and birth cohort. Methods: SSc death records and mid-year population data were collected from the National Statistics Institute. Age-standardized mortality rates were calculated for the overall population and for each sex (male, female) and age group (5-year groups). Significant changes in mortality trends were identified by joinpoint regressions. An age–period–cohort (APC) analysis and potential years of life lost (PYLL) analysis were performed to identify the burden of SSc. Results: Age-standardized mortality rates due to SSc increased from 1.87 (95% CI 1.00–3.02) per 1 000 000 inhabitants between 1980 and 1984, to 2.47 (95% CI 1.74–3.02) per 1 000 000 inhabitants between 2015 and 2019. The relative risk of mortality fell in all groups in cohorts born after 1990. The PYLL rates showed a gradual rise for both sexes. Conclusion: There was an increase in overall SSc mortality in Spain during the 39 years evaluated, although there was a progressive drop for men.


  • Classification of Basal Cell Carcinoma in Ex Vivo Confocal Microscopy Images from Freshly Excised Tissues Using a Deep Learning Algorithm

    by Mercedes Sendín-Martín, Manuel Lara-Caro, Ucalene Harris, Matthew Moronta, Anthony Rossi, Erica Lee, Chih-Shan Jason Chen, Kishwer Nehal, Julián Conejo-Mir Sánchez, José-Juan Pereyra-Rodríguez, et al.